New Study Highlights Impact of Proactive Bone Health Strategies

Gnosis is excited about these findings because they emphasize the importance of the overall population paying closer attention to supporting their bone health – not just those who have discovered their bone health is compromised – and are indicative of how protecting against loss of BMD is critical to health and well-being.  

A groundbreaking three-year study in healthy postmenopausal women showed that MenaQ7 K2 supplementation (180 mcg/daily) made a significant improvement in vitamin K status outside the liver and slowed down the age-related decline in bone mineral content (BMC) and bone mineral density (BMD) in crucial areas like the lumbar spine and femoral neck, which are the bones most prone to weakness. Furthermore, it had a positive impact on bone strength as well. 

“These findings strongly suggest that taking vitamin K2 in the form of MK-7 supplements can help inhibit bone loss and enhance bone strength,” Berger adds, noting that these results also support the health claim endorsed by the European Food Safety Authority (EFSA), affirming the vital connection between vitamin K and the maintenance of normal bone health. “MenaQ7 is the best-researched K2 as MK-7 for preserving bone health, not only in adults but children, too. This new study underscores the opportunity for the population to consume Vitamin K2 as menaquinone-7 to protect their BMC and BMD as they age to remain active and vibrant in their later years.”